Gilead Sciences, Inc.
Choline Salt Forms of an HIV Capsid Inhibitor
Last updated:
Abstract:
The present disclosure relates to choline salts, and crystalline forms thereof, of a compound which is N--((S)-1-(3-(4-chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-- indazol-7-yl)-6-(3-methyl-3-(methylsulfony)but-1-yn-1-yl)pyridin-2-yl)-2-(- 3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)- 3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acet- amide, which is useful in the treatment and prevention of a Retroviridae viral infection including an infection caused by the HIV virus.
Status:
Application
Type:
Utility
Filling date:
26 Jan 2022
Issue date:
11 Aug 2022